Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
7.66
+0.15 (2.00%)
At close: Nov 28, 2025, 1:00 PM EST
7.55
-0.11 (-1.44%)
After-hours: Nov 28, 2025, 4:50 PM EST
Immuneering Market Cap
Immuneering has a market cap or net worth of $494.61 million as of November 28, 2025. Its market cap has increased by 811.45% in one year.
Market Cap
494.61M
Enterprise Value
270.96M
1-Year Change
811.45%
Ranking
Category
Stock Price
$7.66
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has increased from $365.84M to $494.61M, an increase of 35.20%. That is a compound annual growth rate of 7.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 494.61M | 624.05% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |